Stay updated on Pembrolizumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Multiple Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, making the content inaccessible; the previous study details are replaced by the error message with a Home link available.
    Difference
    19%
    Check dated 2026-09-23T01:06:15.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.7.0, replacing the previous v3.6.6, indicating an internal update to the site’s versioning rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-09-16T00:12:35.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The Conditions section no longer displays 'Multiple Myeloma', and the MedlinePlus related topic entry 'MedlinePlus Genetics' (and the related topics header) has been removed.
    Difference
    0.2%
    Check dated 2026-09-08T22:32:49.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.6.5 to v3.6.6, indicating a minor site update. This change likely does not alter the study details or the information presented to users.
    Difference
    0.1%
    Check dated 2026-09-01T21:37:30.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added a line under Study Details showing '2015 ( U.S. NIH Grant/Contract )' to disclose NIH funding for the study. This provides contextual information about sponsorship without altering study criteria or outcomes.
    Difference
    0.1%
    Check dated 2026-08-25T23:25:38.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This update reflects a minor refresh of the page's content or layout as tracked by the site's revision system.
    Difference
    0.1%
    Check dated 2026-08-11T20:03:45.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.